Trial NCT03212807

View at ClinicalTrials.gov 
Org. Study IDs: SDBCC-LYM-16-02

Last trial update was posted on 2018-09-13

MeSH Interventions

Durvalumab Lenalidomide

MeSH Conditions

Lymphoma

Other Conditions

EBV Related Non-Hodgkin's Lymphoma Primary CNS Lymphoma Primary Testicular Lymphoma

Stopping Reasons

FDA Hold for Combination Studies using Imids and PD1/PDL1 Compounds

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID